MANAGEMENT TEAM

Eid E. Haddad, Ph.D. joined ImmunoBiosciences, Inc. as its Senior Research Scientist in February 2006. Dr. Haddad presently serves as V.P. of R&D at ImmunoBiosciences, Inc. Dr. Haddad is also a Visiting Scientist at the Department of Molecular Biomedical Sciences at the College of Veterinary Medicine, North Carolina State University. Prior to joining ImmunoBiosciences, Dr. Haddad held several positions with the most recent being Senior Manager, Global Product Development, at Embrex Inc., a North Carolina biotechnology company, now a part of Pfizer Animal Health. Dr. Haddad worked on the development of novel immune complex vaccines against Infectious bursal disease virus (IBDV) and Newcastle disease virus (NDV) in poultry using the antigen-antibody complex technology, including conducting the required USDA (and global) regulatory licensing studies and field trials for product licensure. He also conducted research on technology application to avian Reovirus (tenosynovitis), avian Infectious bronchitis virus, human Reovirus using a mouse model, and on technology application for the development of multi-viral vaccines. Dr. Haddad has numerous publications and scientific presentations in this area. Dr. Haddad earned his Ph.D. in Physiology from the Pennsylvania State University (PSU), PA, USA in 1989. Dr. Haddad worked as a post doctoral fellow at PSU, then as a post doctoral research associate at University of Arkansas, AR, USA, where he conducted research in the endocrine and the immune-endocrine interactions in poultry and in viral and tumor immunology, respectively. Dr. Haddad earned his B. Sc. & M. Sc. from University of Mosul, in reproductive physiology and lactation in dairy cattle.